Biora Therapeutics, Inc. Common Stock
BIOR Real Time Price USDRecent trades of BIOR by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by BIOR's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Treatment of a disease of the gastrointestinal tract with an immunosuppressant Nov. 26, 2024
-
Patent Title: Gastrointestinal tract detection methods, devices and systems Sep. 17, 2024
-
Patent Title: Electromechanical pill device with localization capabilities Aug. 06, 2024
-
Patent Title: Ingestible device for delivery of therapeutic agent to the gastrointestinal tract Mar. 26, 2024
-
Patent Title: Localization systems and methods for an ingestible device Mar. 05, 2024
-
Patent Title: Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices Jan. 02, 2024
-
Patent Title: Ingestible device for delivery of a dispensable substance Oct. 24, 2023
-
Patent Title: Ingestible device for delivery of therapeutic agent to the gastrointestinal tract Jul. 25, 2023
-
Patent Title: Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor released using an ingestible device Mar. 07, 2023
-
Patent Title: Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist Mar. 07, 2023
-
Patent Title: Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract Jan. 10, 2023
-
Patent Title: Treatment of a disease of the gastrointestinal tract with an immunosuppressant Dec. 13, 2022
-
Patent Title: Ingestible device recovery system Oct. 18, 2022
-
Patent Title: Ingestible device for delivery of therapeutic agent to the gastrointestinal tract Sep. 13, 2022
-
Patent Title: Treatment of a disease of the gastrointestinal tract with a tlr modulator Aug. 30, 2022
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of BIOR in WallStreetBets Daily Discussion
Recent insights relating to BIOR
Recent picks made for BIOR stock on CNBC
ETFs with the largest estimated holdings in BIOR
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BIOR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.